ホーム › PubMed Lab 🤖 自分の AI で使う ⭐ 保存した論文

🔬 PubMed Lab

日本語で入力するだけで、PubMed の英語論文を検索できるリサーチアシスタントです。
卒論・研究テーマ探し、興味のある論文を効率よく見つけられます。

「強迫症(OCD)治療のエビデンス総まとめ:曝露反応妨害法と薬物療法、どちらが効くのか?」の検索結果

105 件中 10 件を表示 (4376 ms) · ⭐ 保存した論文

AI が生成した英語クエリを見る
("obsessive-compulsive disorder"[MeSH] OR OCD) AND ("exposure therapy"[MeSH] OR "response prevention" OR ERP OR "exposure and response prevention") AND ("drug therapy"[MeSH] OR pharmacotherapy OR medication) AND (systematic review[PT] OR meta-analysis[PT] OR "clinical trial"[PT])

💡 OCD治療のERP vs 薬物療法の比較エビデンスを、システマティックレビュー・メタ解析・臨床試験に絞って検索

🎓 卒論・修論テーマを AI が提案

この 5 本の論文を俯瞰して、あなたが実際に卒論・修論で研究できるテーマを 3 つ提案します。

残り 3 / 3 回 (今日)

📖 このサイトの解説記事から (日本語で読める)

PubMed Trivia が過去に取り上げた論文を日本語で解説している記事です。

🔍 PubMed の検索結果

  • Cognitive behavioural therapy with exposure and response prevention in the treatment of obsessive-compulsive disorder: A systematic review and meta-analysis of randomised controlled trials.

    Jemma E Reid, Keith R Laws, Lynne Drummond 他 · Comprehensive psychiatry · 2021

    Cognitive behavioural therapy (CBT), incorporating exposure and response prevention (ERP) is widely recognised as the psychological treatment of choice for obsessive-compulsive disorder (OCD). Uncertainty remains however about the magnitude of the effect of CBT with ERP and the impact of moderating factors in patients with OCD. This systematic review and meta-analysis assessed randomised-controlle…

    📄 PubMed で読む (PMID: 33618297)
  • The effect of exposure and response prevention therapy on obsessive-compulsive disorder: A systematic review and meta-analysis.

    Yuqi Song, Dongxu Li, Shuyu Zhang 他 · Psychiatry research · 2022

    This meta-analysis mainly examined the effect size of exposure and response prevention (ERP) for obsessive-compulsive disorder (OCD) when compared with different control conditions, and the difference in the efficacy of different variants of ERP in the treatment of OCD. Thirty studies were included, involving 39 randomized controlled trials with 1793 participants, from 30 studies up to January 18,…

    📄 PubMed で読む (PMID: 36179591)
  • Cognitive behavioral treatments of obsessive-compulsive disorder. A systematic review and meta-analysis of studies published 1993-2014.

    Lars-Göran Öst, Audun Havnen, Bjarne Hansen 他 · Clinical psychology review · 2015

    Obsessive-compulsive disorder is ranked by the WHO as among the 10 most debilitating disorders and tends to be chronic without adequate treatment. The only psychological treatment that has been found effective is cognitive behavior therapy (CBT). This meta-analysis includes all RCTs (N=37) of CBT for OCD using the interview-based Yale-Brown Obsessive Compulsive Scale, published 1993 to 2014. The e…

    📄 PubMed で読む (PMID: 26117062)
  • Exposure Therapy in Mixed Reality for Obsessive-Compulsive Disorder: A Randomized Clinical Trial.

    Franziska Miegel, Lena Jelinek, Luzie Lohse 他 · JAMA network open · 2025

    Exposure therapy in virtual reality (VR) is well established for anxiety disorders. While early studies show promise for VR-based exposure and response prevention (ERP) in obsessive-compulsive disorder (OCD), a key challenge of traditional VR is the weak sense of presence, deemed crucial for effectiveness. To evaluate the feasibility and efficacy of ERP in mixed reality (MERP). This randomized cli…

    📄 PubMed で読む (PMID: 40392553)
  • Economic Analyses of Obsessive-Compulsive Disorder Interventions: A Systematic Review.

    Emily R Strouphauer, Olivia J Morris, Keaton J Soileau 他 · PharmacoEconomics · 2023

    Obsessive-compulsive disorder (OCD) is a neuropsychiatric condition featuring patterns of obsessions, compulsions, and avoidant behaviors that are often time consuming and distressing to affected individuals. Cognitive-behavioral therapy (CBT) with exposure and response prevention and/or serotonin reuptake inhibitors are first-line treatments for OCD, though other therapeutic interventions may ser…

    📄 PubMed で読む (PMID: 36840747)
  • Ketamine in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review.

    Igor D Bandeira, Daniel H Lins-Silva, Vitor Breseghello Cavenaghi 他 · Harvard review of psychiatry · 2022

    First-line treatment for obsessive-compulsive disorder (OCD) includes exposure and response prevention behavioral therapy and serotonin reuptake inhibitors, particularly in combination. New and more effective treatments are needed, give that recent studies suggest that glutamatergic neurotransmission contributes to the pathophysiology of the disorder. In these circumstances, ketamine, as a potent …

    📄 PubMed で読む (PMID: 35267254)
  • Neural mechanisms underlying exposure and response prevention for obsessive compulsive disorder: A randomized controlled trial.

    Ryan J Jacoby, Jennifer L Greenberg, Aura Hurtado 他 · Behaviour research and therapy · 2025

    Fear extinction is an important treatment target of obsessive-compulsive disorder (OCD). In the current randomized controlled trial, we examined the therapeutic modulation of exposure and response prevention (ERP) on neural activation during fear extinction in OCD to identify mechanisms of action and response biomarkers. Thirty-four patients with OCD were randomized to either 12-weeks of ERP or a …

    📄 PubMed で読む (PMID: 41005270)
  • The effectiveness of exposure and response prevention combined with pharmacotherapy for obsessive-compulsive disorder: A systematic review and meta-analysis.

    Lingyun Mao, Maorong Hu, Lan Luo 他 · Frontiers in psychiatry · 2022

    To systematically evaluate the effectiveness of exposure and response prevention (ERP) combined with medication on obsessive-compulsive disorder (OCD). PubMed, Web of Science, EBSCO, Cochrane, Embase, and Science Direct databases were searched to include randomized controlled trials of ERP combined with medication for OCD that met the criteria. The Yale Brown Obsessive Compulsive Scale was used as…

    📄 PubMed で読む (PMID: 36186855)
  • D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysis.

    Jing Xia, Yanqiu Du, Jiyang Han 他 · Drug design, development and therapy · 2015

    To evaluate the overall effect of D-cycloserine (DCS) augmentation on exposure and response prevention (ERP) therapy for obsessive-compulsive disorder (OCD). Clinical studies on the effect of DCS augmentation on ERP therapy for OCD compared to placebo were included for meta analysis. The primary outcome was the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS). Meta-analyses were performed with a ran…

    📄 PubMed で読む (PMID: 25960632)
  • Structural brain imaging studies offer clues about the effects of the shared genetic etiology among neuropsychiatric disorders.

    Nevena V Radonjić, Jonathan L Hess, Paula Rovira 他 · Molecular psychiatry · 2021

    Genomewide association studies have found significant genetic correlations among many neuropsychiatric disorders. In contrast, we know much less about the degree to which structural brain alterations are similar among disorders and, if so, the degree to which such similarities have a genetic etiology. From the Enhancing Neuroimaging Genetics through Meta-Analysis (ENIGMA) consortium, we acquired s…

    📄 PubMed で読む (PMID: 33456050)